BMP Sunstone Reports Third Quarter 2009 Financi...(e Securities and Exchange Commission. In...)

                    BMP Sunstone Corporation and Subsidiaries
                  Condensed Consolidated Statements of Operation
                ($ amounts, except per share amounts in thousands)

                                            For the Three      For the Nine
                                            months ended       months ended
                                            September 30,      September 30,
                                            2009     2008      2009     2008

    Revenues:
    Third parties                         $33,358  $28,544  $101,001  $72,979
    Related parties                           268    1,959     4,370    5,251
    Total Revenues                         33,626   30,503   105,371   78,230
    Cost of Goods Sold                     17,950   16,676    54,643   40,120
    Gross Profit                           15,676   13,827    50,728   38,110
    Sales and Marketing Expenses            9,811    9,152    33,622   26,251
    General and Administration Expenses     4,825    2,910    12,755    9,886
    Total Operating Expenses               14,636   12,062    46,377   36,137
    Profit From Operations                  1,040    1,765     4,351    1,973
    Other Income (Expense):
    Interest Income                            52        6       159       68
    Interest Expense                         (895)  (1,590)   (3,369)  (4,770)
    Debt Issuance Cost Amortization          (101)    (210)     (326)    (630)
    Equity Method Investment Income           107       --       189      675
    Loss on Early Extinguishment of Debt       --       --    (4,573)      --
    Gain(Loss) on Derivatives                  --       --     1,204       --
    Total Other Income (Expense)             (837)  (1,794)   (6,716)  (4,657)
    
'/>"/>
SOURCE  BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. BMP Sunstone Announces Participation in November Investor Conferences
8. BMP Sunstone Reports Third Quarter 2008 Financial Results
9. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
10. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
11. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference